Interim Results 2021
RNS Number : 4650H Norish PLC 04 August 2021 Norish plc Interim Results 2021 Results Norish plc (AIM: NSH), is pleased to announce its interim results for the six months ended 30 June 2021. Financial Highlights · Sales increased by 19%, from £15.9m to £18.9m. · Operating profit increased by 61%, from £0.94m to £1.51m. · Pre-tax profit increased by 73%, from £0.78m to £1.35m. · Fully diluted adjusted Eps increased by 74%, from 2.06p to 3.58p. · Interest cover stood at 9.9x, at the half year stage. · Net debt increased from £8.7m at December 2020 to £9.5m. Divisional Highlights
| £'m | Cold Store | Sourcing | Dairy | ||||||
| Jun-21 £'000 | Jun-20 £'000 | % Growth | Jun-21 £'000 | Jun-20 £'000 | % Growth | Jun-21 £'000 | Jun-20 £'000 | % Growth | |
| Revenue | 7,938 | 7,083 | 12% | 10,479 | 8,413 | 25% | 508 | 399 | 27% |
| Operating Profit | 1,755 | 1,374 | 28% | 121 | 101 | 20% | 32 | (143) | |
| Operating Margin | 22.1% | 19.4% | 1.2% | 1.2% | 6.3% | (36%) | |||
| Norish plc | ||||||||||||||||
| Consolidated income statement | ||||||||||||||||
| For the six months ended 30 June 2021 | ||||||||||||||||
| Six months | Six months | Year | ||||||||||||||
| ended | ended | ended | ||||||||||||||
| 30 June | 30 June | 31 December | ||||||||||||||
| 2021 | 2020 | 2020 | ||||||||||||||
| (Unaudited) | (Unaudited) | (Audited) | ||||||||||||||
| £'000 | £'000 | £'000 | ||||||||||||||
| Continuing operations | ||||||||||||||||
| Revenue | 18,925 | 15,895 | 33,361 | |||||||||||||
| Cost of sales | (17,130) | (14,659) | (30,389) | |||||||||||||
| Gross profit | 1,795 | 1,236 | 2,972 | |||||||||||||
| Other income | 113 | 88 | 182 | |||||||||||||
| Administrative expenses | (402) | (388) | (865) | |||||||||||||
| Operating profit from continuing operations | 1,506 | 936 | 2,289 | |||||||||||||
| Finance income - interest receivable | - | - | 1 | |||||||||||||
| Finance expenses - lease interest | (87) | (94) | (117) | |||||||||||||
| Finance expenses - interest on bank loans | (65) | (63) | (196) | |||||||||||||
| Profit on continuing activities before taxation | 1,354 | 779 | 1,977 | |||||||||||||
| Income taxes - Corporation tax | (277) | (160) | (224) | |||||||||||||
| Income taxes - Deferred tax | - | - | (245) | |||||||||||||
| Profit for the period attributable to owners of the parent from continuing operations | 1,077 | 619 | 1,508 | |||||||||||||
| Loss from discontinued activities | (69) | - | (71) | |||||||||||||
| Profit for the period | 1,008 | 619 | 1437 | |||||||||||||
| Other comprehensive income | (228) | - | 162 | |||||||||||||
| Total comprehensive income for the year | 780 | 619 | 1,599 | |||||||||||||
| Earnings per share expressed in pence per share: | ||||||||||||||||
| From continuing operations - basic | 3.58p | 2.06p | 5.02p | |||||||||||||
| - diluted | 3.58p | 2.06p | 5.02p | |||||||||||||
| From discontinued operations - basic | (0.23)p | 0p | (0.24)p | |||||||||||||
| - diluted | (0.23)p | 0p | (0.24)p | |||||||||||||
| Norish plc | ||||||||||||||||
| Interim balance sheet | ||||||||||||||||
| As at 30 June 2021 | ||||||||||||||||
| As at | As at | As at | ||||||||||||||
| 30 June | 30 June | 31 December | ||||||||||||||
| 2021 | 2020 | 2020 | ||||||||||||||
| (Unaudited) | (Restated) | (Audited) | ||||||||||||||
| £'000 | £'000 | £'000 | ||||||||||||||
| ASSETS | ||||||||||||||||
| Non-current assets | ||||||||||||||||
| Goodwill | 2,338 | 2,338 | 2,338 | |||||||||||||
| Intangible assets | 1,906 | 807 | 1,269 | |||||||||||||
| Biological assets | 856 | 700 | 770 | |||||||||||||
| Property, plant and equipment | 22,960 | 22,592 | 22,898 | |||||||||||||
| 28,060 | 26,437 | 27,275 | ||||||||||||||
| Current assets | ||||||||||||||||
| Trade and other receivables | 8,494 | 4,838 | 7,526 | |||||||||||||
| Inventories | 157 | 1,025 | 58 | |||||||||||||
| Cash and cash equivalents | 843 | 1,501 | 1,550 | |||||||||||||
| Assets of disposal group classified as held for sale | 270 | 277 | 381 | |||||||||||||
| 9,764 | 7,641 | 9,515 | ||||||||||||||
| TOTAL ASSETS | 37,824 | 34,078 | 36,790 | |||||||||||||
| Equity attributable to equity holders of the parent And non-controlling interest | ||||||||||||||||
| Share capital | 5,640 | 5,640 | 5,640 | |||||||||||||
| Share premium account | 7,321 | 7,321 | 7,321 | |||||||||||||
| Other reserves | (87) | (21) | 141 | |||||||||||||
| Retained earnings | 6,758 | 4,932 | 5,750 | |||||||||||||
| TOTAL EQUITY | 19,632 | 17,872 | 18,852 | |||||||||||||
| Non-current liabilities | ||||||||||||||||
| Borrowings | 5,052 | 5,757 | 5,514 | |||||||||||||
| Deferred tax | 1,244 | 1,002 | 1,244 | |||||||||||||
| 6,296 | 6,759 | 6,758 | ||||||||||||||
| Current liabilities | ||||||||||||||||
| Trade and other payables | 6,119 | 5,526 | 6,288 | |||||||||||||
| Current tax liabilities | 450 | 442 | 151 | |||||||||||||
| Borrowings | 5,327 | 3,479 | 4,741 | |||||||||||||
| 11,896 | 9,447 | 11,180 | ||||||||||||||
| TOTAL EQUITY AND LIABILITIES | 37,824 | 34,078 | 36,790 | |||||||||||||
| Norish plc | ||||||||||||||||
| Consolidated statement of changes in equity For the six months ended 30 June 2021 | ||||||||||||||||
| Share | Share | Other | Treasury | Retained | ||||||||||||
| capital | premium | Reserves | shares | earnings | Total | |||||||||||
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |||||||||||
| At 1 January 2020 | 5,640 | 7,321 | (21) | - | 4,313 | 17,253 | ||||||||||
| Net profit for the financial period | - | - | - | 619 | 619 | |||||||||||
| Total comprehensive income for the period | - | - | - | - | 619 | 619 | ||||||||||
| Issue of share capital | - | - | - | - | - | - | ||||||||||
| Equity dividends paid (recognised directly in equity) | - | - | - | - | - | - | ||||||||||
| Transactions with owners | - | - | - | - | 619 | 619 | ||||||||||
| At 30 June 2020 | 5,640 | 7,321 | (21) | - | 4,932 | 17,872 | ||||||||||
| Net profit/(loss) for the financial period | - | - | - | 818 | 818 | |||||||||||
| Total comprehensive income for the period | - | - | - | 818 | 818 | |||||||||||
| Issue of share capital | - | - | - | - | - | - | ||||||||||
| Equity dividends paid (recognised directly in equity) | - | - | - | - | - | |||||||||||
| Foreign Exchange gain | - | - | 162 | - | - | 162 | ||||||||||
| Transactions with owners | - | - | 162 | - | 818 | 980 | ||||||||||
| At 31 December 2020 | 5,640 | 7,321 | 141 | - | 5,750 | 18,852 | ||||||||||
| Net profit for the financial period | - | - | - | - | 1,008 | 1,008 | ||
| Total comprehensive income for the period | - | - | - | - | 1,008 | 1,008 | ||
| Issue of share capital | - | - | - | - | - | - | ||
| Equity dividends paid (recognised directly in equity) | - | - | - | - | - | - | ||
| Foreign Exchange loss | - | - | (228) | - | - | (228) | ||
| Transactions with owners | - | - | (228) | - | 1,008 | 780 | ||
| At 30 June 2021 | 5,640 | 7,321 | (87) | - | 6,758 | 19,632 |
| Norish plc | |||
| Consolidated cash flow statement | |||
| For the six months ended 30 June 2021 | |||
| Six months | Six months | Year | |
| Ended | ended | Ended | |
| 30 June | 30 June | 31 December | |
| 2021 | 2020 | 2020 | |
| (Unaudited) | (Restated) | (Restated) | |
| £'000 | £'000 | £'000 | |
| Profit on continuing activities before taxation | 1,354 | 779 | 1,977 |
| Gain on biological assets | (113) | (88) | (182) |
| Foreign exchange loss/(gain) | 205 | (51) | (55) |
| Loss on discontinued activities | (69) | - | (71) |
| Finance expenses | 152 | 157 | 316 |
| Finance income | - | - | (1) |
| Depreciation - property, plant and equipment | 987 | 887 | 1,789 |
| 2,516 | 1,684 | 3,773 | |
| Changes in working capital: | |||
| (Increase)/decrease in inventories | (99) | 80 | 1,047 |
| (Increase)/decrease in trade and other receivables | (968) | 2,019 | (669) |
| Increase/(decrease) in trade and other receivables for disposal | 111 | - | (104) |
| Increase/(decrease) in current liabilities held for sale | - | - | - |
| Decrease in payables | (169) | (1,038) | (276) |
| Cash generated from operations | 1,391 | 2,745 | 3,771 |
| Interest paid | (152) | (157) | (316) |
| Interest received | - | - | 1 |
| Taxation refund/(paid) | 22 | 51 | (304) |
| Net cash from operating activities | 1,261 | 2,639 | 3,152 |
| Investing activities | |||
| Investment in intangible assets | (685) | (243) | (705) |
| Purchase of biological assets | (10) | (5) | (65) |
| Sale of biological assets | 8 | 268 | 346 |
| Purchase of property, plant and equipment | (1,177) | (634) | (1,741) |
| Net cash used in investing activities | (1,864) | (614) | (2,165) |
| Financing activities | |||
| Dividends paid to shareholders | - | - | - |
| Invoice finance receipts/ (payments) | 475 | (1,225) | (150) |
| Finance lease capital repayments | (623) | (405) | (845) |
| Finance lease advance | 258 | 215 | 882 |
| Term loan advance | - | - | - |
| Term loan repayments | (214) | (163) | (378) |
| Net cash used in financing activities | (104) | (1,578) | (491) |
| Net (decrease)/increase in cash and cash equivalents | (707) | 447 | 496 |
| Cash and cash equivalents, at beginning of period | 1,550 | 1,054 | 1,054 |
| Cash and cash equivalents end of period | 843 | 1,501 | 1,550 |
| Norish | |
| Aidan Hughes, Finance Director | Telephone: + 44 1293 862 498 |
| Davy | |
| Anthony Farrell | Telephone: + 353 1 679 6363 |